Zhaoke Opthalmology IPO: Promising Drug Candidates; but Commercialisation May Take Longer
Zhaoke's strong drug pipeline demonstrates strong growth potential and some of the company’s drug candidates have the potential to become market...
259 Views
Zhaoke Ophthalmology IPO Initiation: The Eyes Have It
Zhaoke is pre-marketing an HKEx IPO to raise $200 million, according to press reports. Overall, we believe that Zhaoke’s drug assets are attractive.
345 Views
Zhaoke Ophthalmic (兆科眼科) Pre-IPO: Thoughts on Valuation
In this note, we provide a forecast on Zhaoke Ophthalmic's two core products CsA ophthalmic gel and the ZKY001 and an SOTP based valuation for the...
411 Views
ECM Weekly (5th April 2021) - Nayuki, Peter Warren, Linklogis, Zhaoke Ophthalmic, Macrotech Dev
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.
358 Views
Zhaoke Ophthalmic (兆科眼科): Could Be Over-Valued for Pre-IPO Round
The company has an OK management team but strong backing of institutional investors. We think the pre-IPO valuation could be too high.
391 Views